Evidence map›Paper›PMID 23121402›Full record

ArticleAntioxidants & redox signaling2013

An indole derivative protects against acetaminophen-induced liver injury by directly binding to N-acetyl-p-benzoquinone imine in mice.

Ji-Hoon Park, Kang-Sik Seo, Surendar Tadi, Bong-Hyun Ahn, Jung-Uee Lee, Jun-Young Heo, Jeongsu Han, Myoung-Sub Song, Soon-Ha Kim, Yong-Hyeon Yim and 3 more

Abstract read
In one paragraph

Article in Antioxidants & redox signaling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. [Gut microbiota-associated metabolites with drug-induced liver injury].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Chemical science · 2017
    Article
  12. Generation of small molecules to interfere with regulated necrosis.Cellular and molecular life sciences : CMLS · 2016
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Ji-Hoon ParkDepartment of Biochemistry, School of Medicine, Chungnam National University, Daejeon, Korea.
Kang-Sik Seo
Surendar Tadi
Bong-Hyun Ahn
Jung-Uee Lee
Jun-Young Heo
Jeongsu Han
Myoung-Sub Song
Soon-Ha Kim
Yong-Hyeon Yim
Hueng-Sik Choi
Minho Shong
GiRyang Kweon
Chungnam National University · KRLG (India) · INKorea Research Institute of Standards and Science · KRChungnam National University Hospital · KRCreative Research · GBDaejeon Catholic University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsAcetaminophen (APAP)-induced liver injury is mainly due to the excessive formation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) through the formation of a reactive intermediate, N-acetyl-p-benzoquinone imine (NAPQI), in both humans and rodents. Here, we show that the indole-derived synthetic compound has a protective effect against APAP-induced liver injury in C57Bl/6 mice model.

resultsNecroX-7 decreased tert-butylhydroperoxide (t-BHP)- and APAP-induced cell death and ROS/RNS formation in HepG2 human hepatocarcinoma and primary mouse hepatocytes. In mice, NecroX-7 decreased APAP-induced phosphorylation of c-Jun N-terminal kinase (JNK) and 3-nitrotyrosine (3-NT) formation, and also protected mice from APAP-induced liver injury and lethality by binding directly to NAPQI. The binding of NecroX-7 to NAPQI did not require any of cofactors or proteins. NecroX-7 could only scavenge NAPQI when hepatocellular GSH levels were very low. INNOVATION: NecroX-7 is an indole-derived potent antioxidant molecule, which can be bound to some types of radicals and especially NAPQI. It is well known that the NAPQI is a major intermediate of APAP, which causes necrosis of hepatocytes in rodents and humans. Thus, blocking NAPQI formation or eliminating NAPQI are novel strategies for the treatment or prevention of APAP-induced liver injury instead of GSH replenishment.

conclusionOur data suggest that the indole-derivative, NecroX-7, directly binds to NAPQI when hepatic GSH levels are very low and the NAPQI-NecroX-7 complex is secreted to the blood from the liver. NecroX-7 shows more preventive and similar therapeutic effects against APAP-induced liver injury when compared to the effect of N-acetylcysteine in C57Bl/6 mice.

Indexed as

AcetaminophenAnimalsAntioxidantsBenzoquinonesCell DeathChemical and Drug Induced Liver InjuryHepatocytesIminesJNK Mitogen-Activated Protein KinasesMaleMiceOrganic ChemicalsPhosphorylationReactive Nitrogen SpeciesReactive Oxygen SpeciesAcetaminophenAntioxidantsBenzoquinonesIminesJNK Mitogen-Activated Protein KinasesN-acetyl-4-benzoquinoneiminenecrox-7Organic ChemicalsReactive Nitrogen SpeciesReactive Oxygen Species

Identifiers

PMID23121402
PMCPMC3619205
OpenAlexW1971432612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.